«
»

Top

Latest articles published

KesimptaⓇ (ofatumumab): A new treatment for relapsing-remitting multiple sclerosis (RRMS)

Multiple sclerosis

KesimptaⓇ (ofatumumab): A new treatment for relapsing-remitting multiple sclerosis (RRMS)

What are monoclonal antibodies?Ofatumumab is the active ingredient in KesimptaⓇ. It is also a monoclonal antibody.Antibodies are proteins produced by the cells of our immune system (specifically...

Read the article